{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:01:18Z","timestamp":1789948878848,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) carries a poor prognosis, with nearly half of resected patients relapsing within one year. Current National Comprehensive Cancer Network (NCCN) and American Joint Committee on Cancer (AJCC) staging systems inadequately reflect tumor biology. This study aimed to develop and validate preoperative risk scores integrating computed tomography (CT) features and systemic inflammatory markers to predict 12-month recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this two-center retrospective cohort, consecutive patients with histologically confirmed resectable\/borderline PDAC who underwent pancreaticoduodenectomy (2017\u20132024) were included. Standardized preoperative multiphase CT and laboratory data within 28 days before surgery were reviewed. Quantitative and qualitative CT parameters and inflammatory indices were analyzed using multiple imputation and pathway-specific logistic regression for up-front surgery (US) and neoadjuvant therapy (NT) groups.<\/jats:p>\n                    <jats:p>Model performance was evaluated by discrimination, calibration, and decision-curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 544 resections, 133 met eligibility (US\u2009=\u200981; NT\u2009=\u200952). Final models retained tumor size, necrosis, fat stranding, and the C-reactive protein-to-albumin ratio (CAR) and neutrophil-to-lymphocyte ratio (NLR) for US, and tumor size, hepatic-artery contact\u2009\u2265\u200990\u00b0, CAR, NLR, and carcinoembryonic antigen (CEA) for NT. Development area under the curve (AUC) values were 0.84 (US) and 0.81 (NT), and test AUCs were 0.82 and 0.78, respectively, outperforming AJCC 8\u1d57\u02b0 staging (\u0394AUC\u2009+\u20090.19 and +\u20090.20).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compact, pathway-specific preoperative scores combining CT descriptors and inflammatory indices improved prediction of early recurrence compared with AJCC staging, supporting their potential use for individualized surgical and perioperative decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12893-026-03948-3","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:21:36Z","timestamp":1782890496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative CT and inflammatory index\u2013based risk scores for predicting short-term recurrence following resection of pancreatic ductal adenocarcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Mohammad Masih","family":"Mansouri-Tehrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Iraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Safarnezhad Tameshkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mersad","family":"Mansouri Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"4","key":"3948_CR1","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw open. 2021;4(4):e214708\u2013e.","journal-title":"JAMA Netw open"},{"key":"3948_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"3948_CR3","doi-asserted-by":"publisher","unstructured":"Lekka K, Tzitzi E, Giakoustidis A, Papadopoulos V, Giakoustidis D. Contemporary management of borderline resectable pancreatic ductal adenocarcinoma. Ann Hepatobiliary Pancreat Surg. 2019;23(2):97\u2013108. https:\/\/doi.org\/10.14701\/ahbps.2019.23.2.97.","DOI":"10.14701\/ahbps.2019.23.2.97"},{"issue":"6","key":"3948_CR4","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.amjsurg.2022.10.027","volume":"224","author":"EM Curto","year":"2022","unstructured":"Curto EM, Kaza AG, Sturdevant DA, Tuvin DM, Ganai S, Sticca RP. Improved outcomes for borderline resectable adenocarcinoma of the pancreas after neoadjuvant chemotherapy in a community cancer center. Am J Surg. 2022;224(6):1426\u201331.","journal-title":"Am J Surg"},{"issue":"10","key":"3948_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1001\/jamasurg.2024.2485","volume":"159","author":"S Crippa","year":"2024","unstructured":"Crippa S, Malleo G, Mazzaferro V, Langella S, Ricci C, Casciani F, et al. Futility of up-front resection for anatomically resectable pancreatic cancer. JAMA Surg. 2024;159(10):1139\u201347.","journal-title":"JAMA Surg"},{"issue":"4","key":"3948_CR6","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.3390\/curroncol30040282","volume":"30","author":"G Nappo","year":"2023","unstructured":"Nappo G, Donisi G, Capretti G, Ridolfi C, Pagnanelli M, Nebbia M, et al. Early recurrence after upfront surgery for pancreatic ductal adenocarcinoma. Curr Oncol. 2023;30(4):3708\u201320.","journal-title":"Curr Oncol"},{"issue":"1","key":"3948_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s11701-025-02912-2","volume":"19","author":"A Afrooghe","year":"2025","unstructured":"Afrooghe A, Pirmoradian P, Ghasemi M, Mohammadi B, Mehranjani MS, Ahmadi E, et al. Expanding horizons: the role of robotic surgery in modern transplantation practices. J Robotic Surg. 2025;19(1):740.","journal-title":"J Robotic Surg"},{"issue":"9","key":"3948_CR8","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2010.0073","volume":"8","author":"MA Tempero","year":"2010","unstructured":"Tempero MA, Arnoletti JP, Behrman S, Ben-Josef E, Benson AB, Berlin JD, et al. Pancreatic adenocarcinoma. J Natl Compr Canc Netw. 2010;8(9):972\u20131017.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"3948_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","volume":"19","author":"MA Tempero","year":"2021","unstructured":"Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, et al. Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(4):439\u201357.","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"3948_CR10","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1007\/s00268-020-05462-w","volume":"44","author":"E Melloul","year":"2020","unstructured":"Melloul E, Lassen K, Roulin D, Grass F, Perinel J, Adham M, et al. Guidelines for perioperative care for pancreatoduodenectomy: enhanced recovery after surgery (ERAS) recommendations 2019. World J Surg. 2020;44(7):2056\u201384.","journal-title":"World J Surg"},{"issue":"12","key":"3948_CR11","doi-asserted-by":"publisher","first-page":"e183617","DOI":"10.1001\/jamasurg.2018.3617","volume":"153","author":"S Van Roessel","year":"2018","unstructured":"Van Roessel S, Kasumova GG, Verheij J, Najarian RM, Maggino L, De Pastena M, et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 2018;153(12):e183617\u2013e.","journal-title":"JAMA Surg"},{"issue":"6","key":"3948_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.pan.2015.09.008","volume":"15","author":"I Matsumoto","year":"2015","unstructured":"Matsumoto I, Murakami Y, Shinzeki M, Asari S, Goto T, Tani M, et al. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: a multi-center retrospective study. Pancreatology. 2015;15(6):674\u201380.","journal-title":"Pancreatology"},{"issue":"6","key":"3948_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/oncolo\/oyad044","volume":"28","author":"F Crowley","year":"2023","unstructured":"Crowley F, Gandhi S, Rudshteyn M, Sehmbhi M, Cohen DJ. Adherence to NCCN genetic testing guidelines in pancreatic cancer and impact on treatment. Oncologist. 2023;28(6):486\u201393.","journal-title":"Oncologist"},{"issue":"7","key":"3948_CR14","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1245\/s10434-023-13230-y","volume":"30","author":"HA Lima","year":"2023","unstructured":"Lima HA, Alaimo L, Moazzam Z, Endo Y, Woldesenbet S, Katayama E, et al. Disparities in NCCN guideline-compliant care for patients with early-stage pancreatic adenocarcinoma at minority-serving versus non-minority-serving hospitals. Ann Surg Oncol. 2023;30(7):4363\u201372.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"3948_CR15","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1016\/j.acra.2023.03.007","volume":"30","author":"X Bai","year":"2023","unstructured":"Bai X, Wu L, Dai J, Wang K, Shi H, Lu Z, et al. Rim enhancement and peripancreatic fat stranding in preoperative MDCT as predictors for occult metastasis in PDAC patients. Acad Radiol. 2023;30(12):2954\u201361.","journal-title":"Acad Radiol"},{"issue":"1","key":"3948_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40644-024-00653-3","volume":"24","author":"JH Lee","year":"2024","unstructured":"Lee JH, Shin J, Min JH, Jeong WK, Kim H, Choi S-Y, et al. Preoperative prediction of early recurrence in resectable pancreatic cancer integrating clinical, radiologic, and CT radiomics features. Cancer Imaging. 2024;24(1):6.","journal-title":"Cancer Imaging"},{"issue":"3","key":"3948_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.6004\/jnccn.2019.0014","volume":"17","author":"MA Tempero","year":"2019","unstructured":"Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, et al. Pancreatic Adenocarcinoma, Version 1.2019. J Natl Compr Canc Netw. 2019;17(3):202\u201310.","journal-title":"J Natl Compr Canc Netw"},{"issue":"6","key":"3948_CR18","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/jhbp.1282","volume":"30","author":"T Hata","year":"2023","unstructured":"Hata T, Mizuma M, Motoi F, Ohtsuka H, Nakagawa K, Morikawa T, et al. Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection. J Hepatobiliary Pancreat Sci. 2023;30(6):815\u201324.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"20","key":"3948_CR19","doi-asserted-by":"publisher","first-page":"e70352","DOI":"10.1002\/cam4.70352","volume":"13","author":"F de Castro e Borges","year":"2024","unstructured":"de Castro e Borges F, Khajeh E, Nikbakhsh R, Ribeiro C, Maeurer M, Carvalho C, et al. Preoperative inflammatory scores do not accurately predict early recurrence of pancreatic ductal adenocarcinoma after resection: a systematic review and meta-analysis. Cancer Med. 2024;13(20):e70352.","journal-title":"Cancer Med"},{"issue":"1","key":"3948_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13244-025-01915-9","volume":"16","author":"C Qu","year":"2025","unstructured":"Qu C, Zeng P, Li C, Hu W, Yang D, Wang H, et al. A machine learning model based on preoperative multiparametric quantitative DWI can effectively predict the survival and recurrence risk of pancreatic ductal adenocarcinoma. Insights into Imaging. 2025;16(1):38.","journal-title":"Insights into Imaging"},{"issue":"6","key":"3948_CR21","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154\u201362.","journal-title":"Ann Surg"},{"key":"3948_CR22","doi-asserted-by":"publisher","unstructured":"Mansouri-Tehrani MM, Shahnazari R, Iraji H, Mansouri Tehrani MM, Ghasemi M. Optimizing venographic referrals in pelvic congestion syndrome. J Ultrasound Med. https:\/\/doi.org\/10.1002\/jum.70199.","DOI":"10.1002\/jum.70199"},{"issue":"3","key":"3948_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1148\/radiol.212236","volume":"303","author":"S-S Kim","year":"2022","unstructured":"Kim S-S, Lee S, Lee HS, Bang S, Han K, Park M-S. Retrospective evaluation of treatment response in patients with nonmetastatic pancreatic cancer using CT and CA 19\u2009\u2013\u20099. Radiology. 2022;303(3):548\u201356.","journal-title":"Radiology"},{"issue":"6","key":"3948_CR24","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1245\/s10434-024-15105-2","volume":"31","author":"G Belfiori","year":"2024","unstructured":"Belfiori G, Crippa S, Pagnanelli M, Gasparini G, Aleotti F, Camisa PR, et al. Very early recurrence after curative resection for pancreatic ductal adenocarcinoma: proof of concept for a biological R2 definition. Ann Surg Oncol. 2024;31(6):4084\u201395.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3948_CR25","doi-asserted-by":"publisher","first-page":"19783","DOI":"10.1038\/s41598-024-70441-3","volume":"14","author":"SA Mohamed","year":"2024","unstructured":"Mohamed SA, Barlemann A, Steinle V, Nonnenmacher T, G\u00fcttlein M, Hackert T, et al. Performance of different CT enhancement quantification methods as predictors of pancreatic cancer recurrence after upfront surgery. Sci Rep. 2024;14(1):19783.","journal-title":"Sci Rep"},{"issue":"5","key":"3948_CR26","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1245\/s10434-019-08040-0","volume":"27","author":"M Sandini","year":"2020","unstructured":"Sandini M, Negreros-Osuna AA, Qadan M, Hank T, Patino M, Ferrone CR, et al. Main pancreatic duct to parenchymal thickness ratio at preoperative imaging is associated with overall survival in upfront resected pancreatic cancer: M. Sandini et al. Ann Surg Oncol. 2020;27(5):1606\u201312.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3948_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/diagnostics13050963","volume":"13","author":"T Takayanagi","year":"2023","unstructured":"Takayanagi T, Sekino Y, Kasuga N, Ishii K, Nagase H, Nakajima A. Clinical features and prognostic impact of pancreatic ductal adenocarcinoma without dilatation of the main pancreatic duct: A single-center retrospective analysis. Diagnostics. 2023;13(5):963.","journal-title":"Diagnostics"},{"key":"3948_CR28","doi-asserted-by":"publisher","unstructured":"Renzulli M, Cucchetti A, Zucchini V, et al. Rim enhancement on imaging of pancreatic ductal adenocarcinoma: systematic review and meta-analysis of biological and prognostic values. Radiol Med. 2026;131:167\u201376. https:\/\/doi.org\/10.1007\/s11547-025-02131-7.","DOI":"10.1007\/s11547-025-02131-7"},{"issue":"5","key":"3948_CR29","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1245\/s10434-019-08040-0","volume":"27","author":"M Sandini","year":"2020","unstructured":"Sandini M, Negreros-Osuna AA, Qadan M, Hank T, Patino M, Ferrone CR, et al. Main pancreatic duct to parenchymal thickness ratio at preoperative imaging is associated with overall survival in upfront resected pancreatic cancer. Ann Surg Oncol. 2020;27(5):1606\u201312.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3948_CR30","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.pan.2021.08.010","volume":"21","author":"X Guo","year":"2021","unstructured":"Guo X, Gao S, Yu J, Zhou Y, Gao C, Hao J. The imaging features of extrapancreatic perineural invasion (EPNI) in pancreatic cancer: a comparative retrospective study. Pancreatology. 2021;21(8):1516\u201323.","journal-title":"Pancreatology"},{"issue":"1","key":"3948_CR31","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/s41598-021-81322-4","volume":"11","author":"E Khristenko","year":"2021","unstructured":"Khristenko E, Shrainer I, Setdikova G, Palkina O, Sinitsyn V, Lyadov V. Preoperative CT-based detection of extrapancreatic perineural invasion in pancreatic cancer. Sci Rep. 2021;11(1):1800.","journal-title":"Sci Rep"},{"issue":"7","key":"3948_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamaoncol.2018.0329","volume":"4","author":"JE Murphy","year":"2018","unstructured":"Murphy JE, Wo JY, Ryan DP, Jiang W, Yeap BY, Drapek LC, et al. Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial. JAMA Oncol. 2018;4(7):963\u20139.","journal-title":"JAMA Oncol"},{"key":"3948_CR33","doi-asserted-by":"publisher","first-page":"841819","DOI":"10.3389\/fonc.2022.841819","volume":"12","author":"S Li","year":"2022","unstructured":"Li S, Zhang G, Lu Y, Zhao T, Gao C, Liu W, et al. Perioperative serum scoring systems predict early recurrence and poor prognosis of resectable pancreatic cancer. Front Oncol. 2022;12:841819.","journal-title":"Front Oncol"},{"issue":"5","key":"3948_CR34","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1097\/SLA.0000000000004148","volume":"275","author":"H Kato","year":"2022","unstructured":"Kato H, Kishiwada M, Hayasaki A, Chipaila J, Maeda K, Noguchi D, et al. Role of Serum Carcinoma Embryonic Antigen (CEA) level in localized pancreatic adenocarcinoma: cea level before operation is a significant prognostic indicator in patients with locally advanced pancreatic cancer treated with neoadjuvant therapy followed by surgical resection: a retrospective analysis. Ann Surg. 2022;275(5):e698\u2013707.","journal-title":"Ann Surg"},{"issue":"19","key":"3948_CR35","doi-asserted-by":"publisher","first-page":"4672","DOI":"10.3390\/cancers14194672","volume":"14","author":"H Kang","year":"2022","unstructured":"Kang H, Kim S-S, Sung MJ, Jo JH, Lee HS, Chung MJ, et al. Evaluation of the 8th edition AJCC staging system for the clinical staging of pancreatic cancer. Cancers (Basel). 2022;14(19):4672.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"3948_CR36","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/JCO.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne E, Suker M, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the dutch randomized phase III PREOPANC trial. J Clin Oncol. 2020;38(16):1763\u201373.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3948_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13546805.2021.1991295","volume":"27","author":"M Arbabi","year":"2022","unstructured":"Arbabi M, Dezhdar Z, Amini B, Dehnavi AZ, Ghasemi M. Depression and anxiety increase the odds of developing delirium in ICU patients; a prospective observational study. Cogn Neuropsychiatry. 2022;27(1):1\u201310.","journal-title":"Cogn Neuropsychiatry"},{"key":"3948_CR38","doi-asserted-by":"publisher","unstructured":"Woodward JM, Myneni AA, Liu H, Berkebile M, L\u2019Huillier JC, Nader N, et al. The impact of hospital mergers: exploring the importance of flagship designation, hospital volume, and surgeon volume on perioperative outcomes following whipple procedure. J Surg Oncol. 2026;133(5):660\u20139. https:\/\/doi.org\/10.1002\/jso.70202.","DOI":"10.1002\/jso.70202"},{"issue":"2","key":"3948_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1245\/s10434-020-08767-1","volume":"28","author":"NL Eng","year":"2021","unstructured":"Eng NL, Mustin DE, Lovasik BP, Turgeon MK, Gamboa AC, Shah MM, et al. Relationship between cancer diagnosis and complications following pancreatoduodenectomy for duodenal adenoma: NL Eng. Ann Surg Oncol. 2021;28(2):1097\u2013105.","journal-title":"Ann Surg Oncol"},{"key":"3948_CR40","doi-asserted-by":"publisher","unstructured":"Changazi SH, Ahmed Q, Bhatti S, Siddique S, Raffay EA, Farooka MW, et al. Whipple procedure: a five-year clinical experience in tertiary care center. Cureus. 2020;12(11):e11466. https:\/\/doi.org\/10.7759\/cureus.11466.","DOI":"10.7759\/cureus.11466"},{"issue":"3","key":"3948_CR41","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.surg.2012.05.022","volume":"152","author":"C Fern\u00e1ndez-del Castillo","year":"2012","unstructured":"Fern\u00e1ndez-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo JA, Ferrone CR, Thayer SP, et al. Evolution of the whipple procedure at the massachusetts general hospital. Surgery. 2012;152(3):S56\u201363.","journal-title":"Surgery"},{"issue":"4","key":"3948_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/hpb.12355","volume":"17","author":"L Stevens","year":"2015","unstructured":"Stevens L, Pathak S, Nunes QM, Pandanaboyana S, Macutkiewicz C, Smart N, et al. Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. HPB (Oxford). 2015;17(4):285\u201391.","journal-title":"HPB (Oxford)"},{"issue":"8Supplement1","key":"3948_CR43","doi-asserted-by":"publisher","first-page":"6232","DOI":"10.1158\/1538-7445.AM2025-6232","volume":"85","author":"A Mohammed","year":"2025","unstructured":"Mohammed A, Gebremedhen AI, Souleymane M, Shanti I, Wiese J, Roy S, et al. Pancreatic cancer epidemiology and impacts in patients admitted with sepsis: Insights from a nationwide inpatient sample. Cancer Res. 2025;85(8Supplement1):6232.","journal-title":"Cancer Res"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03948-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03948-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:31:23Z","timestamp":1789947083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03948-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3948"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03948-3","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"25 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approved by the ethics committee of Iran University of Medical Sciences (IR.IUMS.REC.1402.813). The study adhered to the Declaration of Helsinki. In accordance with national regulations, the requirement for informed consent was waived by the institutional ethics committee of Iran University of Medical Sciences because of the retrospective study design and the use of fully de-identified data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was not obtained from participants because no identifiable personal information, clinical details, or identifying images are included in this publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"627"}}